.

Puma Biotechnology reported $59.52M in Sales Revenues for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Agios Pharmaceuticals AGIO:US $ 5.58M 4.75M
Alnylam Pharmaceuticals ALNY:US $ 224.82M 11.56M
Amgen AMGN:US $ 6594M 356M
Biogen BIIB:US $ 2589.1M 57.3M
Biomarin Pharmaceutical BMRN:US $ 533.8M 14.44M
Bluebird Bio BLUE:US $ 1.52M 0.43M
Clovis Oncology CLVS:US $ 32.14M 2.1M
Daiichi Sankyo 4568:JP Y 280317M 46392M
Esperion Therapeutics ESPR:US $ 18.84M 5K
Exelixis EXEL:US $ 419.43M 63.45M
Gilead Sciences GILD:US $ 6260M 330M
Glaxosmithkline GSK:US $ 6929M 2851M
Intercept Pharmaceuticals ICPT:US $ 71.76M 16.82M
Macrogenics MGNX:US $ 26.01M 14.91M
Mirati Therapeutics MRTX:US $ 5.36M 4.65M
Moderna Inc MRNA:US 4.75B 1.32B
Novartis NOVN:VX SF 13085M 271M
Pfizer PFE:US $ 27742M 2081M
Ptc Therapeutics PTCT:US $ 165.53M 16.79M
Puma Biotechnology PBYI:US $ 59.52M 13.78M
Regeneron Pharmaceuticals REGN:US $ 2857.2M 107.9M
Roche Holding ROG:VX 16.44B 474M
Sangamo Biosciences SGMO:US $ 29.38M 1.15M
Sarepta Therapeutics SRPT:US $ 233.49M 22.66M
Seattle Genetics SGEN:US $ 497.5M 71.04M
Takeda 4502:JP Y 972465M 99176M
Tg Therapeutics TGTX:US $ 0.59M 1.42M
Ultragenyx Pharmaceutical RARE:US $ 89.34M 9.41M
Vanda Pharmaceuticals VNDA:US $ 128.78M 68.59M
Vertex Pharmaceuticals VRTX:US $ 2196.2M 98.7M
YTE INCY:US $ 911.4M 178.16M